hs-CRP


Also found in: Medical.
AcronymDefinition
hs-CRPHigh-Sensitivity C-Reactive Protein (test for heart disease risk)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Highly sensitive C-reactive protein (hs-CRP) was quantitatively estimated by the immunoturbidimetric method (ITA) and absorbance was read at 570 nm.
(15) In 2019, Tabrizi, et al, conducted a systematic review and meta-analysis of 15 randomized controlled trials which suggests that taking curcumin-containing supplements may exert antiinflammatory properties through a significant reduction inIL-6 and hs-CRP. (16)
This retrospective research was conducted to examine the efficacy of weight loss accomplished by calorie-restricted diets on the plasma levels of leptin, homocysteine, fibrinogen, high-sensitivity C-reactive protein (hs-CRP), triglycerides, total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), fasting blood glucose, insulin and uric acid in people with obesity.
Normal distribution of quantitative variables (protein C, protein S, antithrombin III, DD, FDPs, CRP, hs-CRP, WBC count, procalcitonin) was evaluated using Kolmogorov-Smirnow Z (K - S) test.
Since the data in adolescent population are scarce, we aimed to estimate the potential relationship between VAI, anthropometric parameters (i.e., BMI, WC, waist to height ratio [WHtR], respectively), and inflammation as measured by hs-CRP in a cohort of adolescent girls from 16 to 19 years old.
We found that co-supplementation with omega-3 and vitamin E for 12 weeks in patients with PCOS had beneficial effects on CIMT and hs-CRP levels, but did not affect NO values.
A fully automated analyzer had used to analyze the biochemical parameters such as TC, TG, HDL, LDL, OxLDL, hs-CRP, and Apo-Al and Apo-B.
Patients in RAG also had improvements in the results of nutritional hematological examination (RBP, PA, Tf, Hb), Inflammation biomarkers (TNF-a, IL-6, SAA, Hs-CRP, COHb) and the BODE index.
The aim of this study was to evaluate the procalcitonin and hs-CRP levels in ISSNHL patients and assess their correlations with the clinical prognosis.
Participants were excluded if they did not have information available on demographic characteristics; body composition indices, such as weight, height, waist circumference (WC), hip circumference (HC), fat-free body mass, and BFP; or metabolic parameters, such as low-density lipoprotein-cholesterol (LDL-C), high-density lipoprotein-cholesterol (HDL-C), total cholesterol (TC), triglyceride (TG), fasting blood glucose (FBG), 2 h postprandial blood glucose (2h PBG), glycosylated hemoglobin (HbA1c), fasting insulin (FINS), insulin resistance index (HOMA-IR), high-sensitivity C-reactive protein level (hs-CRP), and white blood cell count (WBC).
The outcome measures included mean reduction in ALT, AST, hs-CRP, MDA, and FLI score and improvement in hepatic steatosis grade on USG from baseline to the end of intervention.